White House prioritizes omicron-targeted vaccines over 2nd boosters

The Biden administration is pushing for vaccine-makers to tweak their vaccines for better efficacy against omicron subvariants BA.4 and BA.5 while suppressing efforts to deploy a second booster to adults younger than 50, The Washington Post reported July 22. 

Advertisement

Federal health officials, who asked for anonymity, told the Post the modified vaccines are expected in mid-September, a few weeks before the earlier deadline.

Currently, two booster shots are recommended for adults 50 and older and immunocompromised people 12 and older. As cases rise again and current vaccine efficacy wanes with each new variant, health experts have advised not waiting for the updated vaccines, which await regulators’ approval. 

A final decision has not been made, but more directives are expected soon, the Post reported. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.